HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of novel physiological load-adaptive control strategies for ventricular assist devices.

Abstract
Terminal heart failure (HF) is the most prevalent cause of death in the Western world and the implantation of a left ventricular assist device (LVAD) has become the gold standard therapy today. Most of the actually implanted devices are driven at a constant speed (CS) regardless of the patient's physiological demand. A new physiological controller [power ratio (PR) controller], which keeps a constant ratio between LVAD power and left ventricular power, a previous concept [preload responsive speed (PRS) controller], which adds a variable LVAD power to reach a defined stroke work, and a CS controller were compared with an unimpaired ventricle in a full heart computer simulation model. The effects of changes in preload, afterload and left ventricular contractility are displayed by global hemodynamics and ventricular pressure-volume loops. Both physiological controllers demonstrated the desired load dependency, whereas the PR controller exceeded the PRS controller in response to an increased load and contractility. Response was inferior when preload or contractility was decreased. Thus, the PR controller might lead to an increased exercise tolerance of the patient. Additional studies are required to evaluate the controllers in vivo.
AuthorsMoriz Habigt, Maike Ketelhut, Jonas Gesenhues, Frank Schrödel, Marc Hein, Mare Mechelinck, Thomas Schmitz-Rode, Dirk Abel, Rolf Rossaint
JournalBiomedizinische Technik. Biomedical engineering (Biomed Tech (Berl)) Vol. 62 Issue 2 Pg. 149-160 (Apr 01 2017) ISSN: 1862-278X [Electronic] Germany
PMID27855113 (Publication Type: Journal Article)
Topics
  • Computer Simulation
  • Feedback, Physiological
  • Heart Failure (diagnosis, physiopathology, therapy)
  • Heart-Assist Devices
  • Humans
  • Models, Cardiovascular
  • Therapy, Computer-Assisted (instrumentation, methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: